Phase 3
N=34
Strength Training in Walking Tolerance in Intermittent Claudication Patients
Peripheral Arterial Disease · Hypertension · Diabetes
Bottom Line
View on ClinicalTrials.gov: NCT00879697 ↗Enrolled (actual)
34
Serious AEs
0.0%
Results posted
Apr 2009
Primary outcome: Primary: Total Walking Distance — 618; 572 meter — p=<0.05
Study Design & Population
- Study type
- Interventional
- Phase
- Phase 3
- Interventions
- Walking Training (Behavioral); Strength Training (Behavioral)
- Age
- Adult, Older Adult · 50+ yrs
- Sex
- All
- Sponsor
- University of Sao Paulo
- Primary completion
- Aug 2008
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Total Walking Distance |
618; 572 | <0.05 sig |
Summary
Background: Muscle atrophy and reduced leg strength are related to exercise intolerance in patients with intermittent claudication (IC), suggesting that strength training (ST) could improve exercise performance in these patients.
Objective: Analyze the effects of ST in walking capacity in patients with IC comparing with walking training (WT) effects.
Intervention: Patients were randomized into ST and WT. Both groups trained twice a week, for 12 weeks, at the same rate of perceived exertion. ST consisted of 3 sets of 10 repetitions of whole body exercises. WT consisted of 15 two-minute bouts of walking intercalated with 2 minutes of resting.
Measurements: Walking capacity, peak VO2, walking economy, ankle brachial index, ischemic window and knee extension strength
Eligibility Criteria
Inclusion Criteria
- Fontaine stage II peripheral arterial disease(14)
- Symptoms of intermittent claudication for at least 6 months
- Ankle/brachial index (ABI) at rest ≤ 0.90 in 1 or 2 legs
- Reduction of ABI after treadmill test
- Exercise tolerance limited by intermittent claudication
Exclusion Criteria
- Presence of chronic lung disease
- Inability to obtain ABI measurement due to noncompressible vessels
- Exercise tolerance limited by factors other than claudication (e.g., dyspnea or orthopedic problems)
- Poorly controlled blood pressure
- Presence of electrocardiogram response suggestive of myocardial ischemia during the exercise test
- History of revascularization in the previous year
Data sourced from ClinicalTrials.gov (NCT00879697). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.